Identification of a new human coronavirus, Nature Medicine, vol.10, issue.4, pp.368-73, 2004. ,
DOI : 10.1038/nm1024
Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia, Journal of Virology, vol.79, issue.2, pp.884-95, 2005. ,
DOI : 10.1128/JVI.79.2.884-895.2005
Severe acute respiratory syndrome, Nature Medicine, vol.94, issue.12s, pp.88-97, 2004. ,
DOI : 10.1172/JCI200421328
URL : https://hal.archives-ouvertes.fr/pasteur-00167032
The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex, Journal of Virology, vol.77, issue.16, pp.8801-8812, 2003. ,
DOI : 10.1128/JVI.77.16.8801-8811.2003
Synthesis and Characterization of a Native, Oligomeric Form of Recombinant Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein, Journal of Virology, vol.78, issue.19, pp.10328-10363, 2004. ,
DOI : 10.1128/JVI.78.19.10328-10335.2004
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, vol.426, issue.6965, pp.450-454, 2003. ,
DOI : 10.1038/nature02145
Expression cloning of functional receptor used by SARS coronavirus, Biochemical and Biophysical Research Communications, vol.315, issue.2, pp.439-483, 2004. ,
DOI : 10.1016/j.bbrc.2004.01.076
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus, Proceedings of the National Academy of Sciences, vol.101, issue.44, pp.15748-53, 2004. ,
DOI : 10.1073/pnas.0403812101
pH-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus Is Mediated by the Spike Glycoprotein and Enhanced by Dendritic Cell Transfer through DC-SIGN, Journal of Virology, vol.78, issue.11, pp.5642-50, 2004. ,
DOI : 10.1128/JVI.78.11.5642-5650.2004
Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry, Proceedings of the National Academy of Sciences, vol.101, issue.12, pp.4240-4245, 2004. ,
DOI : 10.1073/pnas.0306446101
S Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Mediates Entry into Hepatoma Cell Lines and Is Targeted by Neutralizing Antibodies in Infected Patients, Journal of Virology, vol.78, issue.12, pp.6134-6176, 2004. ,
DOI : 10.1128/JVI.78.12.6134-6142.2004
Neutralizing Antibodies in Patients with Severe Acute Respiratory Syndrome???Associated Coronavirus Infection, The Journal of Infectious Diseases, vol.190, issue.6, pp.1119-1145, 2004. ,
DOI : 10.1086/423286
Development and Characterization of a Severe Acute Respiratory Syndrome???Associated Coronavirus???Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice, The Journal of Infectious Diseases, vol.191, issue.4, pp.507-521, 2005. ,
DOI : 10.1086/427242
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets, The Lancet, vol.363, issue.9427, pp.2139-2180, 2004. ,
DOI : 10.1016/S0140-6736(04)16506-9
Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice, Journal of Virology, vol.78, issue.7, pp.3572-3579, 2004. ,
DOI : 10.1128/JVI.78.7.3572-3577.2004
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice, Proceedings of the National Academy of Sciences, vol.101, issue.17, pp.6641-6647, 2004. ,
DOI : 10.1073/pnas.0401939101
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus, Nature Medicine, vol.162, issue.8, pp.871-876, 2004. ,
DOI : 10.1128/JVI.77.19.10394-10403.2003
Evaluation of Human Monoclonal Antibody 80R for Immunoprophylaxis of Severe Acute Respiratory Syndrome by an Animal Study, Epitope Mapping, and Analysis of Spike Variants, Journal of Virology, vol.79, issue.10, pp.5900-5906, 2005. ,
DOI : 10.1128/JVI.79.10.5900-5906.2005
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice, Nature, vol.428, issue.6982, pp.561-565, 2004. ,
DOI : 10.1038/nature02463
Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein, Virology, vol.334, issue.2, pp.160-165, 2005. ,
DOI : 10.1016/j.virol.2005.01.042
A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice, Vaccine, vol.24, issue.17, pp.3624-3655, 2006. ,
DOI : 10.1016/j.vaccine.2006.01.059
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus, Journal of General Virology, vol.87, issue.3 ,
DOI : 10.1099/vir.0.81579-0
Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine, Vaccine, vol.24, issue.7, pp.1028-1062, 2006. ,
DOI : 10.1016/j.vaccine.2005.06.038
Immunization with Modified Vaccinia Virus Ankara-Based Recombinant Vaccine against Severe Acute Respiratory Syndrome Is Associated with Enhanced Hepatitis in Ferrets, Journal of Virology, vol.78, issue.22, pp.12672-12678, 2004. ,
DOI : 10.1128/JVI.78.22.12672-12676.2004
Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses, Proceedings of the National Academy of Sciences, vol.102, issue.3, pp.797-801, 2005. ,
DOI : 10.1073/pnas.0409065102
Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization, J Virol, vol.64, issue.3, pp.1407-1416, 1990. ,
Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages, J Virol, vol.66, issue.2, pp.956-65, 1992. ,
Virology: SARS virus infection of cats and ferrets, Nature, vol.425, issue.6961, p.915, 2003. ,
DOI : 10.1038/425915a
Aetiology: Koch's postulates fulfilled for SARS virus, Nature, vol.78, issue.6937, p.240, 2003. ,
DOI : 10.1038/89098
Severe Acute Respiratory Syndrome Coronavirus Infection of Golden Syrian Hamsters, Journal of Virology, vol.79, issue.1, pp.503-514, 2005. ,
DOI : 10.1128/JVI.79.1.503-511.2005
DC-SIGN and L-SIGN Are High Affinity Binding Receptors for Hepatitis C Virus Glycoprotein E2, Journal of Biological Chemistry, vol.278, issue.22, pp.20358-66, 2003. ,
DOI : 10.1074/jbc.M301284200
URL : https://hal.archives-ouvertes.fr/hal-01061433
Processing, Stability, and Receptor Binding Properties of Oligomeric Envelope Glycoprotein from a Primary HIV-1 Isolate, Journal of Biological Chemistry, vol.275, issue.45, pp.35137-35182, 2000. ,
DOI : 10.1074/jbc.M003868200
Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E, Journal of General Virology, vol.86, issue.5, pp.1423-1457, 2005. ,
DOI : 10.1099/vir.0.80671-0
A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs, Proceedings of the National Academy of Sciences, vol.101, issue.37, pp.13584-13593, 2004. ,
DOI : 10.1073/pnas.0405297101
Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant, Vaccine, vol.16, issue.2-3, pp.2-3286, 1998. ,
DOI : 10.1016/S0264-410X(97)00168-0
A simple method for estimating fifty percent endpoints, Am J Hyg, vol.27, pp.493-500, 1938. ,
C-type Lectins L-SIGN and DC-SIGN Capture and Transmit Infectious Hepatitis C Virus Pseudotype Particles, Journal of Biological Chemistry, vol.279, issue.31, pp.32035-32080, 2004. ,
DOI : 10.1074/jbc.M402296200
Severe Acute Respiratory Syndrome Associated Coronavirus Is Detected in Intestinal Tissues of Fatal Cases, The American Journal of Gastroenterology, vol.42, issue.1, pp.169-76, 2005. ,
DOI : 10.1016/S0006-2952(02)01121-8
Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestis, Vaccine, vol.16, issue.8, pp.761-768, 1998. ,
DOI : 10.1016/S0264-410X(97)00305-8
Expression of Immunogenic Glycoprotein S Polypeptides from Transmissible Gastroenteritis Coronavirus in Transgenic Plants, Virology, vol.249, issue.2, pp.352-360, 1998. ,
DOI : 10.1006/viro.1998.9315
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine, Biochemical and Biophysical Research Communications, vol.324, issue.2, pp.773-81, 2004. ,
DOI : 10.1016/j.bbrc.2004.09.106
Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies, Virus Research, vol.46, issue.1-2, pp.111-135, 1996. ,
DOI : 10.1016/S0168-1702(96)01390-1
Assembly of coronavirus spike protein into trimers and its role in epitope expression, J Virol, vol.64, issue.11, pp.5367-75, 1990. ,
Adjuvants for human vaccines???current status, problems and future prospects, Vaccine, vol.13, issue.14, pp.1263-76, 1995. ,
DOI : 10.1016/0264-410X(95)00011-O
Vaccines for Mucosal Immunity to Combat Emerging Infectious Diseases, Emerging Infectious Diseases, vol.6, issue.2, pp.123-155, 2000. ,
DOI : 10.3201/eid0602.000204
Mucosal Immunization with Surface-Displayed Severe Acute Respiratory Syndrome Coronavirus Spike Protein on Lactobacillus casei Induces Neutralizing Antibodies in Mice, Journal of Virology, vol.80, issue.8, pp.4079-87, 2006. ,
DOI : 10.1128/JVI.80.8.4079-4087.2006
Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract, The Journal of Immunology, vol.173, issue.3, pp.1978-86, 2004. ,
DOI : 10.4049/jimmunol.173.3.1978
Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing Antibodies, The Journal of Immunology, vol.174, issue.8, pp.4908-4923, 2005. ,
DOI : 10.4049/jimmunol.174.8.4908
Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines, Virology, vol.334, issue.1, pp.74-82, 2005. ,
DOI : 10.1016/j.virol.2005.01.034
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association, Proceedings of the National Academy of Sciences, vol.101, issue.8, pp.2536-2577, 2004. ,
DOI : 10.1073/pnas.0307140101
Identification of an Antigenic Determinant on the S2 Domain of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Capable of Inducing Neutralizing Antibodies, Journal of Virology, vol.78, issue.13, pp.6938-6983, 2004. ,
DOI : 10.1128/JVI.78.13.6938-6945.2004
Neutralization and Antibody-Dependent Enhancement of Dengue Viruses, Adv Virus Res, vol.60, pp.421-67, 2003. ,
DOI : 10.1016/S0065-3527(03)60011-4
Studies on the Pathogenesis of Dengue Infection in Monkeys. II. Clinical Laboratory Responses to Heterologous Infection, Journal of Infectious Diseases, vol.128, issue.1, pp.15-22, 1973. ,
DOI : 10.1093/infdis/128.1.15
Enhancing antibodies in HIV infection, Parasitology, vol.115, issue.7, pp.127-167, 1997. ,
DOI : 10.1017/S0031182097001819
Infectivity-Enhancing Antibodies to Ebola Virus Glycoprotein, Journal of Virology, vol.75, issue.5, pp.2324-2354, 2001. ,
DOI : 10.1128/JVI.75.5.2324-2330.2001
Antibody-dependent enhancement of viral infection: molecular mechanisms andin vivo implications, Reviews in Medical Virology, vol.10, issue.6, pp.387-98, 2003. ,
DOI : 10.1002/rmv.405
Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome, Tissue Antigens, vol.9, issue.4, pp.291-297, 2005. ,
DOI : 10.1086/429631
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry, Proceedings of the National Academy of Sciences, vol.102, issue.33, pp.11876-81, 2005. ,
DOI : 10.1073/pnas.0505577102
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection, Proceedings of the National Academy of Sciences, vol.102, issue.35, pp.12543-12550, 2005. ,
DOI : 10.1073/pnas.0503203102
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides, Proceedings of the National Academy of Sciences, vol.101, issue.22, pp.8455-60, 2004. ,
DOI : 10.1073/pnas.0400576101
Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity, Journal of General Virology, vol.74, issue.4, pp.745-754, 1993. ,
DOI : 10.1099/0022-1317-74-4-745
Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement, J Virol, vol.69, issue.5, pp.2858-62, 1995. ,
Structural Bases of Fc??R Functions, International Reviews of Immunology, vol.139, issue.1-2, pp.1-27, 1997. ,
DOI : 10.1172/JCI118420
Multiple organ infection and the pathogenesis of SARS, The Journal of Experimental Medicine, vol.10, issue.3, pp.415-439, 2005. ,
DOI : 10.1038/sj.cr.7290158
SARS Vaccine Protective in Mice, Emerging Infectious Diseases, vol.11, issue.8, pp.1312-1316, 2005. ,
DOI : 10.3201/eid1108.041003